ARTICLE I
“The name of this corporation is l0X Genomics, Inc. (the “Corporation”).
ARTICLE II
The address of the Corporation’s registered office in the State of Delaware is 160 Greentree Drive, Suite 101, in the City of Dover, County of Kent, Zip Code 19904. The name of its registered agent at such address is National Registered Agents, Inc.
ARTICLE III
The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware.
ARTICLE IV
(A) Classes of Stock. The Corporation is authorized to issue three classes of stock to be designated, respectively, “Class A Common Stock,” “Class B Common Stock,” and “Preferred Stock.” The total number of shares which the Corporation is authorized to issue is 258,859,871 shares. 75,955,000 shares shall be Class A Common Stock, each with a par value of $0.00001 per share, 115,000,000 shares shall be Class B Common Stock, each with a par value of $0.00001 per share, and 67,904,871 shares shall be Preferred Stock. The Class A Common Stock and Class B Common Stock shall be collectively referred to herein as, the “Common Stock.”
(B) Powers, Preferences, Special Rights and Restrictions of Preferred Stock. The Preferred Stock authorized by this Seventh Amended and Restated Certificate of Incorporation (the “Restated Certificate”) shall be divided into series as provided herein. 5,523,394 shares of Preferred Stock shall be designated “Series A-1 Preferred Stock”, each with a par value of $0.00001 per share, 20,486,543 shares of Preferred Stock shall be designated “Series A-2 Preferred Stock,” each with a par value of $0.00001 per share, 16,972,477 shares of Preferred Stock shall be designated “Series B Preferred Stock,” each with a par value of $0.00001 per share, 16,747,799 shares of Preferred Stock shall be designated “Series C Preferred Stock,” each with a par value of $0.00001 per share, 5,224,658 shares of Preferred Stock shall be designated “Series D Preferred Stock,” each with a par value of $0.00001 per share and 2,950,000 shares of Preferred Stock shall be designated “Series D-1 Preferred Stock,” each with a par value of $0.00001 per share. The powers, preferences, special rights and restrictions granted to and imposed on the Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series D-1 Preferred Stock are as set forth below in this Article IV(B).
1. Dividend Provisions. The holders of shares of Series D Preferred Stock and Series D-1 Preferred Stock shall be entitled to receive dividends, on a pari passu basis, out of any assets legally available therefor, prior and in preference to any declaration or payment of any dividend (payable other than in Common Stock or other securities and rights convertible into or entitling the holder thereof to receive, directly or indirectly, additional shares of Common Stock of the Corporation) on Series C Preferred Stock, Series B Preferred Stock, Series A-2 Preferred Stock, Series A-1 Preferred Stock, or Common Stock of the Corporation, at the rate of $0.7656
2